PT - JOURNAL ARTICLE AU - RM Wirnsberger AU - M Drent AU - N Hekelaar AU - MH Breteler AU - S Drent AU - EF Wouters AU - PN Dekhuijzen TI - Relationship between respiratory muscle function and quality of life in sarcoidosis AID - 10.1183/09031936.97.10071450 DP - 1997 Jul 01 TA - European Respiratory Journal PG - 1450--1455 VI - 10 IP - 7 4099 - http://erj.ersjournals.com/content/10/7/1450.short 4100 - http://erj.ersjournals.com/content/10/7/1450.full SO - Eur Respir J1997 Jul 01; 10 AB - In sarcoidosis, pulmonary and general symptoms often do not correlate with radiographic stage and routinely performed lung function tests. Asymptomatic muscle involvement in sarcoidosis is common, but little is known about respiratory muscle involvement. The aim of this study was to investigate any relationships between persistent complaints and/or quality of life and respiratory muscle strength and endurance, respectively. Measurements of maximal inspiratory and expiratory mouth pressures (PI,max and PE,max), respiratory muscle endurance and routine lung function were made in 18 patients with sarcoidosis. To assess health status and quality of life, patients completed the Sickness Impact Profile (SIP). Respiratory muscle strength and endurance time were lower in the patient group than in a group of healthy controls (p=0.05). Compared to a general population, the patients with sarcoidosis were found to be limited in physical and psychosocial functioning. The respiratory muscle endurance time correlated with the SIP subscales "mobility" (r=-0.56; p<0.01), and "body care and movement" (r=-0.79; p<0.001). The total lung capacity (TLC), inspiratory vital capacity (IVC) and forced expiratory volume in one second (FEV1) were normal in all subjects. In conclusion, patients with sarcoidosis and normal lung function showed reduced respiratory muscle strength and endurance time. Correlations were found between these indices and both symptoms and certain Sickness Impact Profile domains. Therefore, we suggest inclusion of measurements of respiratory muscle strength in the assessment and follow-up of patients with sarcoidosis.